Ingfrid Salvesen Haldorsen

Stilling

Professor, Radiologist

Tilhørighet

Forskning

Ingfrid Haldorsen er lege og spesialist i radiologi med lang klinisk erfaring innen abdominal- og gynekologisk radiologi. Hun disputerte i 2009 og har siden 2013 vært ansatt i bistilling som professor i radiologi ved UiB. Siden 2020 har Ingfrid Haldorsen ledet Mohn Medical Imaging and Visualization Centre. Forskningsgruppen hennes Bergen Cancer Imaging Research Group jobber særlig med gynekologisk kreftavbildning og samarbeider tett med Bergen gynekologiske kreftforskningsgruppe ved Kvinneklinikken/UiB.

Publikasjoner
Brev til redaktøren
Vitenskapelig artikkel
Vitenskapelig oversiktsartikkel/review
Errata
Vitenskapelig foredrag
Poster
Doktorgradsavhandling
Vitenskapelig antologi/Konferanseserie
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
Sammendrag/abstract
Populærvitenskapelig artikkel
Fagartikkel

Se en full oversikt over publikasjoner i Cristin

  • M. K. Halle, M. Sødal, D. Forsse, H. Engerud, K. Woie, N. G. Lura, K. S. Wagner-Larsen, J. Trovik, B. I. Bertelsen, I. S. Haldorsen, and others, “A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease,” British journal of cancer, vol. 124, iss. 10, pp. 1690-1698, 2021. doi:10.1038/s41416-021-01305-0[BibTeX] [Download PDF]
  • S. W. Vrede, W. J. van Weelden, N. C. M. Visser, J. Bulten, L. J. M. van der Putten, K. van de Vijver, M. Santacana, E. Colas, A. Gil-Moreno, C. P. Moiola, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, J. Huvila, M. Koskas, V. Weinberger, M. Bednarikova, J. Hausnerova, A. A. van der Wurff, X. Matias-Guiu, F. Amant, M. P. L. M. Snijders, H. V. N. Küsters-Vandevelde, C. Reijnen, and J. M. A. Pijnenborg, “Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer,” Gynecologic Oncology, vol. 161, iss. 3, pp. 787-794, 2021. doi:https://doi.org/10.1016/j.ygyno.2021.03.031[BibTeX] [Download PDF]
  • I. K. Nordaas, G. Dimcevski, O. H. Gilja, R. F. Havre, I. S. Haldorsen, and T. Engjom, “Diagnostic Accuracy of Computed Tomography Scores in Chronic Pancreatitis,” Pancreas, vol. 50, iss. 4, pp. 549-555, 2021. doi:10.1097/MPA.0000000000001803[BibTeX] [Download PDF]
  • H. Aase, A. Danielsen, S. Hoff, ÅS. Holen, I. Haldorsen, T. Hovda, B. Hanestad, C. Sandvik, and S. Hofvind, “Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography,” European Journal of Radiology, p. 109753, 2021. doi:https://doi.org/10.1016/j.ejrad.2021.109753[BibTeX] [Download PDF]
  • T. Engjom, I. K. Nordaas, E. Tjora, G. Dimcevski, I. S. Haldorsen, S. S. Olesen, A. M. Drewes, K. Zviniene, G. Barauskas, H. R. Søe. Jespersen, N. Jensen, A. Borch, C. Nøjgaard, S. Novovic, S. S. Kardasheva, A. Okhlobystin, T. Hauge, A. Waage, and J. B. Frøkjær, “Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: A study of 959 cases from the Scandinavian Baltic Pancreatic Club (SBPC) imaging database,” Pancreatology, 2021. doi:https://doi.org/10.1016/j.pan.2021.02.023[BibTeX] [Download PDF]
  • K. E. Fasmer, E. Hodneland, J. A. Dybvik, K. Wagner-Larsen, J. Trovik, Ø. Salvesen, C. Krakstad, and I. H. Haldorsen, “Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer,” Journal of Magnetic Resonance Imaging, vol. 53, iss. 3, pp. 928-937, 2021. doi:10.1002/jmri.27444[BibTeX] [Download PDF]
  • E. Hodneland, J. A. Dybvik, K. S. Wagner-Larsen, V. Solteszova, A. Z. Munthe-Kaas, K. E. Fasmer, C. Krakstad, A. Lundervold, A. S. Lundervold, Ø. Salvesen, B. J. Erickson, and I. Haldorsen, “Automated segmentation of endometrial cancer on MR images using deep learning,” Scientific Reports, vol. 11, iss. 1, p. 179, 2021. doi:10.1038/s41598-020-80068-9[BibTeX] [Download PDF]
  • H. Donkers, K. E. Fasmer, J. Mcgrane, J. M. A. Pijnenborg, R. Bekkers, I. S. Haldorsen, and K. Galaal, “The role of sarcopenic obesity in high-grade endometrial cancer,” International Journal of Gynecology & Obstetrics, 2021. doi:10.1002/ijgo.13591[BibTeX] [Download PDF]
  • H. Jacob, J. A. Dybvik, S. Ytre-Hauge, K. E. Fasmer, E. A. Hoivik, J. Trovik, C. Krakstad, and I. S. Haldorsen, “An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome and Specific Genetic Alterations in Endometrial Cancer,” Journal of Clinical Medicine, vol. 10, iss. 3, 2021. doi:10.3390/jcm10030538[BibTeX] [Download PDF]
  • H. Donkers, K. E. Fasmer, J. Mcgrane, J. M. A. Pijnenborg, R. Bekkers, I. S. Haldorsen, and K. Galaal, “Obesity and visceral fat: Survival impact in high-grade endometrial cancer,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 256, pp. 425-432, 2021. doi:10.1016/j.ejogrb.2020.11.050[BibTeX] [Download PDF]
  • D. Forsse, H. F. Berg, O. Bozickovic, H. Engerud, M. K. Halle, E. A. Hoivik, K. Woie, H. M. J. Werner, I. S. Haldorsen, J. Trovik, and C. Krakstad, “Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer,” Gynecologic Oncology, 2020. doi:10.1016/j.ygyno.2020.12.002[BibTeX] [Download PDF]
  • E. Mörth, K. Wagner-Larsen, E. Hodneland, C. Krakstad, I. Haldorsen, S. Bruckner, and N. Smit, “RadEx: Integrated Visual Exploration of Multiparametric Studies for Radiomic Tumor Profiling,” , vol. 39, iss. 7, pp. 611-622, 2020. doi:10.1111/cgf.14172[BibTeX] [Download PDF]
  • E. Mörth, I. S. Haldorsen, S. Bruckner, and N. N. Smit, “ParaGlyder: Probe-driven Interactive Visual Analysis for Multiparametric Medical Imaging Data,” in Advances in Computer Graphics, 2020, pp. 351-363. doi:10.1007/978-3-030-61864-3_29[BibTeX] [Abstract] [Download PDF]
  • N. Moshina, H. S. Aase, A. S. Danielsen, I. S. Haldorsen, C. I. Lee, S. Zackrisson, and S. Hofvind, “Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial,” Radiology, 2020. doi:10.1148/radiol.2020201150[BibTeX] [Download PDF]
  • S. Ytre-Hauge, Ø. O. Salvesen, C. Krakstad, J. Trovik, and I. Haldorsen, “Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer,” Clinical Radiology, 2020. doi:10.1016/j.crad.2020.07.037[BibTeX] [Download PDF]
  • M. V. Lisitskaya, S. S. Olesen, P. Svarc, M. Ebrahim, A. B. Jensen, C. Nøjgaard, P. Nørregaard, A. M. Drewes, I. S. Haldorsen, T. Engjom, and others, “Systematic approach for assessment of imaging features in chronic pancreatitis: a feasibility and validation study from the Scandinavian Baltic Pancreatic Club (SBPC) database,” Abdominal Radiology, pp. 1-13, 2020. doi:10.1007/s00261-020-02466-x[BibTeX] [Download PDF]
  • A. Losnegård, L. A. Reisæter, O. J. Halvorsen, J. Jurek, J. Assmus, J. B. Arnes, A. Honoré, J. A. Monssen, E. Andersen, I. S. Haldorsen, and others, “Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate-and high-risk prostate cancer patients,” Acta Radiologica, p. 0284185120905066, 2020. doi:10.1177/0284185120905066[BibTeX] [Download PDF]
  • T. Engjom, E. Tjora, F. Erchinger, A. Madzak, G. Dimcevski, J. B. Frøkjær, and I. S. Haldorsen, “Secretin-Stimulated Magnetic Resonance Imaging Reveals Variable Diagnostic Accuracy According to Etiology in Pancreatic Disease,” Pancreas, vol. 49, iss. 3, pp. 361-367, 2020. doi:10.1097/MPA.0000000000001491[BibTeX] [Download PDF]
  • C. Reijnen, E. Gogou, N. C. M. Visser, H. Engerud, J. Ramjith, L. J. M. van der Putten, K. van de Vijver, M. Santacana, P. Bronsert, J. Bulten, M. Hirschfeld, E. Colas, A. Gil-Moreno, A. Reques, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, and others, “Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study,” PLOS Medicine, vol. 17, iss. 5, pp. 1-19, 2020. doi:10.1371/journal.pmed.1003111[BibTeX] [Abstract] [Download PDF]
  • H. F. Berg, Z. Ju, M. Myrvold, K. E. Fasmer, M. K. Halle, E. A. Hoivik, S. N. Westin, J. Trovik, I. S. Haldorsen, G. B. Mills, and others, “Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma,” British Journal of Cancer, pp. 1-9, 2020. doi:10.1038/s41416-020-0745-6[BibTeX] [Download PDF]
  • K. E. Fasmer, A. Gulati, J. A. Dybvik, S. Ytre-Hauge, Ø. Salvesen, J. Trovik, C. Krakstad, and I. S. Haldorsen, “Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer,” European Radiology, pp. 1-11, 2020. doi:10.1007/s00330-019-06622-w[BibTeX] [Download PDF]
  • T. Fonnes, E. Strand, K. E. Fasmer, H. F. Berg, H. Espedal, K. Sortland, I. Stefansson, L. Bjørge, I. S. Haldorsen, C. Krakstad, and others, “Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models,” Cancers, vol. 12, iss. 2, p. 370, 2020. doi:10.3390/cancers12020370[BibTeX] [Download PDF]
  • H. Engerud, H. F. Berg, M. Myrvold, M. K. Halle, L. Bjorge, I. S. Haldorsen, E. A. Hoivik, J. Trovik, and C. Krakstad, “High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer,” Gynecologic Oncology, 2020. doi:10.1016/j.ygyno.2020.01.020[BibTeX] [Download PDF]
  • E. Strand, I. L. Tangen, K. E. Fasmer, H. Jacob, M. K. Halle, E. A. Hoivik, B. Delvoux, J. Trovik, I. S. Haldorsen, A. Romano, and others, “Blood Metabolites Associate with Prognosis in Endometrial Cancer,” Metabolites, vol. 9, iss. 12, p. 302, 2019. doi:10.3390/metabo9120302[BibTeX] [Download PDF]
  • D. Forsse, I. Tangen, K. Fasmer, M. Halle, K. Viste, B. Almås, B-E. Bertelsen, J. Trovik, I. Haldorsen, and C. Krakstad, “Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling,” Gynecologic Oncology, 2019. doi:10.1016/j.ygyno.2019.11.123[BibTeX] [Download PDF]
  • H. Espedal, T. Fonnes, K. E. Fasmer, C. Krakstad, and I. S. Haldorsen, “Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy,” Cancers, vol. 11, iss. 12, p. 1885, 2019. doi:10.3390/cancers11121885[BibTeX] [Download PDF]
  • C. Reijnen, J. IntHout, L. F. Massuger, F. Strobbe, H. V. Küsters-Vandevelde, I. S. Haldorsen, M. P. Snijders, and J. M. Pijnenborg, “Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis,” The Oncologist 2019, 2019. doi:10.1634/theoncologist.2019-0117[BibTeX] [Download PDF]
  • I. S. Haldorsen, N. Lura, J. Blaakær, D. Fischerova, and H. M. J. Werner, “What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?,” Current Oncology Reports, vol. 21, iss. 9, p. 77, 2019. doi:10.1007/s11912-019-0824-0[BibTeX] [Download PDF]
  • W. J. van Weelden, K. E. Fasmer, I. L. Tangen, J. IntHout, K. Abbink, A. E. van Herwaarden, C. Krakstad, L. F. Massuger, I. S. Haldorsen, and J. M. Pijnenborg, “Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study,” BMC Cancer, vol. 19, iss. 1, p. 547, 2019. doi:10.1186/s12885-019-5770-6[BibTeX] [Download PDF]
  • C. Reijnen, W. J. van Weelden, M. S. Arts, J. P. Peters, P. F. Rijken, K. Van de Vijver, M. Santacana, P. Bronsert, J. Bulten, M. Hirschfeld, E. Colas, A. Gil-Moreno, A. Reques, G. Mancebo, C. Krakstad, J. Trovik, I. S. Haldorsen, J. Huvila, M. Koskas, V. Weinberger, L. Minar, E. Jandakova, M. P. L. M. Snijders, S. van den Berg-van Erp, H. V. N. Kusters-Vandevelde, X. Matias-Guiu, F. Amant, ENITEC-consortium, L. F. A. G. Massuger, J. Bussink, and J. M. A. Pijnenborg, “Poor outcome in hypoxic endometrial carcinoma is related to vascular density,” British journal of cancer, vol. 120, iss. 11, p. 1037, 2019. doi:10.1038/s41416-019-0461-2[BibTeX] [Download PDF]
  • S. Hofvind, Å. S. Holen, H. S. Aase, N. Houssami, S. Sebuødegård, T. A. Moger, I. S. Haldorsen, and L. A. Akslen, “Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial,” The Lancet Oncology, vol. 20, iss. 6, pp. 795-805, 2019. doi:10.1016/S1470-2045(19)30161-5[BibTeX] [Download PDF]
  • H. S. Aase, Å. S. Holen, K. Pedersen, N. Houssami, I. S. Haldorsen, S. Sebuødegård, B. Hanestad, and S. Hofvind, “A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial,” European radiology, vol. 29, iss. 3, pp. 1175-1186, 2019. doi:10.1007/s00330-018-5690-x[BibTeX] [Download PDF]
  • H. Engerud, K. Hope, H. F. Berg, K. E. Fasmer, I. L. Tangen, I. S. Haldorsen, J. Trovik, and C. Krakstad, “Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer,” PloS one, vol. 14, iss. 1, p. e0210585, 2019. doi:10.1371/journal.pone.0210585[BibTeX] [Download PDF]
  • I. L. Tangen, K. E. Fasmer, G. F. Konings, A. Jochems, B. Delvoux, S. Xanthoulea, T. Stokowy, E. Strand, H. F. Berg, S. Auriola, J. Trovik, M. R. Häkkinen, and I. S. Haldorsen, “Blood steroids are associated with prognosis and fat distribution in endometrial cancer,” Gynecologic oncology, 2018. doi:10.1016/j.ygyno.2018.10.024[BibTeX] [Download PDF]
  • V. R. Bollineni, S. Ytre-Hauge, A. Gulati, M. K. Halle, K. Woie, Ø. Salvesen, J. Trovik, C. Krakstad, and I. S. Haldorsen, “The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients,” European Journal of Hybrid Imaging, vol. 2, iss. 1, p. 24, 2018. doi:10.1186/s41824-018-0042-2[BibTeX] [Download PDF]
  • S. Ytre-Hauge, J. A. Dybvik, A. Lundervold, Ø. O. Salvesen, C. Krakstad, K. E. Fasmer, H. M. Werner, B. Ganeshan, E. Hoivik, L. Bjørge, J. Trovik, and I. Haldorsen, “Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer,” Journal of Magnetic Resonance Imaging, vol. 48, iss. 6, pp. 1637-1647, 2018. doi:10.1002/jmri.26184[BibTeX] [Download PDF]
  • J. B. Frøkjær, F. Akisik, A. Farooq, B. Akpinar, A. Dasyam, A. M. Drewes, I. S. Haldorsen, G. Morana, J. P. Neoptolemos, S. S. Olesen, M. Petrone, A. Sheel, T. Shimosoegawa, and D. Whitcomb, “Guidelines for the Diagnostic Cross Sectional Imaging and Severity Scoring of Chronic Pancreatitis,” Pancreatology, vol. 18, iss. 7, pp. 764-773, 2018. doi:10.1016/j.pan.2018.08.012[BibTeX] [Download PDF]
  • G. Konings, N. Saarinen, B. Delvoux, L. Kooreman, P. Koskimies, C. Krakstad, K. Fasmer, I. Haldorsen, A. Zaffagnini, M. Häkkinen, S. Auriola, L. Dubois, N. Lieuwes, F. Verhaegen, L. Schyns, R. Kruitwagen, E. Consortium, S. Xanthoulea, and R. A, “Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure,” International journal of molecular sciences, vol. 19, iss. 9, p. 2547, 2018. doi:10.3390/ijms19092547[BibTeX] [Download PDF]
  • T. Engjom, G. Kavaliauskiene, E. Tjora, F. Erchinger, G. Wathle, B. N. Lærum, R. Pål. Njølstad, F. J. Brøndum, O. H. Gilja, G. Dimcevski, and I. S. Haldorsen, “Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI,” PloS one, vol. 13, iss. 7, p. e0201019, 2018. doi:10.1371/journal.pone.0201019[BibTeX] [Download PDF]
  • T. Fonnes, J. Trovik, P. Edqvist, K. E. Fasmer, J. Marcickiewicz, S. Tingulstad, A. C. Staff, L. Bjørge, F. Amant, I. S. Haldorsen, H. Werner, L. Akslen, I. Tangen, and C. Krakstad, “Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 125, iss. 13, pp. 1695-1703, 2018. doi:10.1111/1471-0528.15403[BibTeX] [Download PDF]
  • K. Fuglsang, I. S. Haldorsen, E. A. Lundqvist, G. Lindahl, H. Roed, K. Woie, P. Pakarinen, A. Thoroddsen, M. Anttila, and J. Blaakær, “Cervical cancer staging, pretreatment planning and surgical treatment in the Nordic countries–survey from the Surgical Subcommittee of the Nordic Society of Gynecological Oncology,” Acta Obstetricia et Gynecologica Scandinavica, 2018. doi:10.1111/aogs.13388[BibTeX] [Download PDF]
  • T. Engjom, K. D. Pham, F. Erchinger, I. S. Haldorsen, O. H. Gilja, G. Dimcevski, and R. F. Havre, “Good Agreement Between Transabdominal and Endoscopic Ultrasound of the Pancreas in Chronic Pancreatitis,” Ultraschall in der Medizin-European Journal of Ultrasound, 2018. doi:10.1055/a-0583-8254[BibTeX] [Download PDF]
  • K. E. Fasmer, A. Bjørnerud, S. Ytre-Hauge, R. Grüner, I. L. Tangen, H. M. Werner, L. Bjørge, Ø. O. Salvesen, J. Trovik, C. Krakstad, and I. Haldorsen, “Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer,” Acta Radiologica, vol. 59, iss. 8, pp. 1010-1017, 2018. doi:10.1177/0284185117740932[BibTeX] [Download PDF]
  • T. Engjom, E. Tjora, G. Wathle, F. Erchinger, B. N. Lærum, O. H. Gilja, I. S. Haldorsen, and G. Dimcevski, “Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging,” European radiology, vol. 28, iss. 4, pp. 1495-1503, 2018. doi:10.1007/s00330-017-5115-2[BibTeX] [Download PDF]
  • S. Ytre-Hauge, M. Esmaeili, T. E. Sjøbakk, R. Grüner, K. Woie, H. M. Werner, C. Krakstad, L. Bjørge, Ø. O. Salvesen, I. M. Stefansson, J. Trovik, B. TF, and I. Haldorsen, “In vivo MR spectroscopy predicts high tumor grade in endometrial cancer,” Acta Radiologica, vol. 59, iss. 4, pp. 497-505, 2018. doi:10.1177/0284185117733297[BibTeX] [Download PDF]
  • S. Hofvind, N. Moshina, Å. Holen, A. S. Danielsen, C. I. Lee, N. Houssami, H. S. Aase, L. A. Akslen, and I. S. Haldorsen, “Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening,” Radiology, p. 203936. doi:10.1148/radiol.2021203936[BibTeX] [Download PDF]